カテゴリー： 世界, 医療/バイオ, Allied Market Research

気管支インターベンションの世界市場2021-2031：機会分析・産業予測

【英語タイトル】Interventional Pulmonology Market By Product (Bronchoscopes, Electromagnetic Navigation Bronchoscopy System, Pleuroscopes, Respiratory Endotherapy Devices, Airway Stents, Pleural Catheters, Endobronchial Valves, Bronchial Thermoplasty Systems), By Indication (Asthma, COPD, Lung Cancer, Tracheal and Bronchial Stenosis, Others), By End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Allied Market Researchが出版した調査資料（ALD23JUN068）・商品コード：ALD23JUN068
・発行会社（調査会社）：Allied Market Research
・発行日：2023年3月
・ページ数：280
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

アライドマーケットリサーチ社の市場調査レポートでは、世界の気管支インターベンション市場規模が、2021年の37億ドルから2031年には69億ドルまで拡大し、2022年から2031年までの予測期間中、年平均成長率は5％を記録すると推測されています。当レポートでは、気管支インターベンションの世界市場について多面的に調査・分析を行い、イントロダクション、エグゼクティブサマリー、市場概要、製品別（気管支鏡、電磁ナビゲーション気管支鏡検査システム、胸腔鏡、呼吸器内視鏡治療、その他）分析、疾患別（喘息、COPD、肺がん、気管・気管支狭窄、その他）分析、エンドユーザー別（病院、外来手術センター、診断センター、専門診療所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米/中東・アフリカ）分析、競争状況、企業情報などの内容を整理しています。なお、記載されている企業情報には、Huger Medical Instrument Co. Ltd、Medtronic Plc、Boston Scientific Corporation、Olympus Corporation、fujifilm corporation、Becton、Smith’s Group Plc、cook medical、Vygon、clarus medical llcなどが含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の気管支インターベンション市場規模：製品別
- 気管支鏡の市場規模
- 電磁ナビゲーション気管支鏡検査システムの市場規模
- 胸腔鏡の市場規模
- 呼吸器内視鏡治療の市場規模
- その他気管支インターベンションの市場規模
・世界の気管支インターベンション市場規模：疾患別
- 喘息における市場規模
- COPDにおける市場規模
- 肺がんにおける市場規模
- 気管・気管支狭窄における市場規模
- その他疾患における市場規模
・世界の気管支インターベンション市場規模：エンドユーザー別
- 病院における市場規模
- 外来手術センターにおける市場規模
- 診断センターにおける市場規模
- 専門診療所における市場規模
- その他エンドユーザーにおける市場規模
・世界の気管支インターベンション市場規模：地域別
- 北米の気管支インターベンション市場規模
- ヨーロッパの気管支インターベンション市場規模
- アジア太平洋の気管支インターベンション市場規模
- 中南米/中東・アフリカの気管支インターベンション市場規模
・競争状況
・企業情報

世界の気管支インターベンション市場は、2021年の37億ドルから2031年には69億ドルに達すると予測され、2022年から2031年までの年平均成長率は5.0%となる見込みです。

気管支インターベンションは、内視鏡やその他のツールを使用して、肺や胸部に関連する疾患の診断や治療を行います。これらの処置は、特別な訓練を受けた肺専門医（肺のスペシャリスト）によって行われます。気管支インターベンションは、気道の圧迫、腫瘍、癌、結核、その他の気道狭窄の原因など、肺の主な問題に対する診断・治療サービスを提供しています。世界的な医療費の増加が肺科学市場の成長を促進しています。各国政府は医療インフラやサービスに投資しており、個人も予防医療の重要性を認識するようになっています。このため、呼吸器科サービスへの需要が増加しており、これが気管支インターベンション市場の成長を促進しています。

手ごろな価格で利用しやすい呼吸器診療の必要性は極めて重要であり、医療従事者は世界的に患者の健康状態を改善するために、呼吸器診療のコスト削減に取り組む必要があります。呼吸器内科で使用される特殊な医療機器の購入費用も高額であり、特に低所得国の小規模な診療所や病院にとっては課題となり得ます。このため、先進的な呼吸器科治療がさらに行き届かなくなり、先進国と発展途上国の間で医療の質の格差が拡大する可能性があり、気管支インターベンション市場の成長の妨げになると予想されます。
革新的な肺科学製品の開発に重点が置かれるようになり、遠隔医療サービスも台頭していることから、新たな市場機会が生まれると予想されます。遠隔医療サービスは、肺専門医が遠隔で患者を診断し、患者の所在地では受けられない可能性のある治療を提供するのに役立っています。低侵襲外科手術、呼吸補助装置、画像技術などの呼吸器科技術の進歩が市場拡大の原動力となっています。これにより、呼吸器内科市場のプレーヤーに新たなビジネスチャンスが生まれることが期待され、今後の市場拡大の原動力となりそうです。

COVID-19パンデミックは、気管支インターベンション市場に大きな影響を与えています。パンデミックの発生に伴い、人工呼吸器、酸素濃縮器、フェイスマスクなどの呼吸器関連機器や装置の需要が増加しました。しかし、パンデミックによっていくつかの呼吸器関連品目のサプライチェーンが寸断され、品不足と価格高騰が発生しました。さらに、多くの病院や医療機関が肺機能検査や睡眠検査などの緊急性のない治療を延期または中止したため、肺専門医や関連企業の収入が減少しました。

本レポートに掲載されている主要企業には、Huger Medical Instrument Co. Ltd、Medtronic Plc、Boston Scientific Corporation、Olympus Corporation、富士フイルム株式会社、Becton、Smith’s Group Plc、Cook Medical、Vygon、Clarus Medical LLCなどがあります。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの気管支インターベンション市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、気管支インターベンション市場の有力な機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・気管支インターベンション市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界の気管支インターベンション市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
エンドユーザー別
病院
外来手術センター
診断センター
専門クリニック
その他

製品別
気管支鏡
電磁ナビゲーション気管支鏡システム
胸腔鏡
呼吸器内治療装置
気道ステント
胸膜カテーテル
気管支内バルブ
気管支サーモプラスティシステム

疾患別
喘息
COPD
肺がん
気管・気管支狭窄
その他

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
イギリス
フランス
スペイン
イタリア
その他のヨーロッパ
・アジア太平洋
中国
日本
インド
韓国
オーストラリア
その他のアジア太平洋地域
・LAMEA
ブラジル
アラブ首長国連邦
サウジアラビア
南アフリカ
その他の地域

〈主要市場プレイヤー〉
Huger Medical Instrument Co. Ltd
Medtronic Plc
Boston Scientific Corporation
Olympus Corporation
富士フイルム株式会社
Becton
Smith’s Group Plc
cook medical
Vygon
clarus medical llc

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
3.6. Average Selling Price
3.7. Brand Share Analysis
3.8. Key Regulation Analysis
3.9. Market Share Analysis
3.10. Patent Landscape
3.11. Regulatory Guidelines
3.12. Value Chain Analysis
CHAPTER 4: INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Bronchoscopes
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Electromagnetic Navigation Bronchoscopy System
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Pleuroscopes
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Respiratory Endotherapy Devices
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Airway Stents
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
4.7. Pleural Catheters
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market share analysis by country
4.8. Endobronchial Valves
4.8.1. Key market trends, growth factors and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market share analysis by country
4.9. Bronchial Thermoplasty Systems
4.9.1. Key market trends, growth factors and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market share analysis by country
CHAPTER 5: INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Asthma
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. COPD
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Lung Cancer
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Tracheal and Bronchial Stenosis
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory Surgical Centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Diagnostic Centers
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Specialty Clinics
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Others
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
CHAPTER 7: INTERVENTIONAL PULMONOLOGY MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product
7.2.3. Market size and forecast, by Indication
7.2.4. Market size and forecast, by End-user
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product
7.2.5.1.3. Market size and forecast, by Indication
7.2.5.1.4. Market size and forecast, by End-user
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product
7.2.5.2.3. Market size and forecast, by Indication
7.2.5.2.4. Market size and forecast, by End-user
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product
7.2.5.3.3. Market size and forecast, by Indication
7.2.5.3.4. Market size and forecast, by End-user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product
7.3.3. Market size and forecast, by Indication
7.3.4. Market size and forecast, by End-user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product
7.3.5.1.3. Market size and forecast, by Indication
7.3.5.1.4. Market size and forecast, by End-user
7.3.5.2. UK
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product
7.3.5.2.3. Market size and forecast, by Indication
7.3.5.2.4. Market size and forecast, by End-user
7.3.5.3. France
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product
7.3.5.3.3. Market size and forecast, by Indication
7.3.5.3.4. Market size and forecast, by End-user
7.3.5.4. Spain
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product
7.3.5.4.3. Market size and forecast, by Indication
7.3.5.4.4. Market size and forecast, by End-user
7.3.5.5. Italy
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product
7.3.5.5.3. Market size and forecast, by Indication
7.3.5.5.4. Market size and forecast, by End-user
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product
7.3.5.6.3. Market size and forecast, by Indication
7.3.5.6.4. Market size and forecast, by End-user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product
7.4.3. Market size and forecast, by Indication
7.4.4. Market size and forecast, by End-user
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product
7.4.5.1.3. Market size and forecast, by Indication
7.4.5.1.4. Market size and forecast, by End-user
7.4.5.2. Japan
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product
7.4.5.2.3. Market size and forecast, by Indication
7.4.5.2.4. Market size and forecast, by End-user
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product
7.4.5.3.3. Market size and forecast, by Indication
7.4.5.3.4. Market size and forecast, by End-user
7.4.5.4. South Korea
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product
7.4.5.4.3. Market size and forecast, by Indication
7.4.5.4.4. Market size and forecast, by End-user
7.4.5.5. Australia
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product
7.4.5.5.3. Market size and forecast, by Indication
7.4.5.5.4. Market size and forecast, by End-user
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product
7.4.5.6.3. Market size and forecast, by Indication
7.4.5.6.4. Market size and forecast, by End-user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product
7.5.3. Market size and forecast, by Indication
7.5.4. Market size and forecast, by End-user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product
7.5.5.1.3. Market size and forecast, by Indication
7.5.5.1.4. Market size and forecast, by End-user
7.5.5.2. United Arab Emirates
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product
7.5.5.2.3. Market size and forecast, by Indication
7.5.5.2.4. Market size and forecast, by End-user
7.5.5.3. Saudi Arabia
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Product
7.5.5.3.3. Market size and forecast, by Indication
7.5.5.3.4. Market size and forecast, by End-user
7.5.5.4. South Africa
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Product
7.5.5.4.3. Market size and forecast, by Indication
7.5.5.4.4. Market size and forecast, by End-user
7.5.5.5. Rest of LAMEA
7.5.5.5.1. Key market trends, growth factors and opportunities
7.5.5.5.2. Market size and forecast, by Product
7.5.5.5.3. Market size and forecast, by Indication
7.5.5.5.4. Market size and forecast, by End-user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Medtronic Plc
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.2. Boston Scientific Corporation
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.3. Olympus Corporation
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.4. fujifilm corporation
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.5. Becton
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.6. Smith’s Group Plc
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.7. cook medical
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.8. Vygon
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.9. clarus medical llc
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.10. Huger Medical Instrument Co. Ltd
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot

LIST OF TABLES
TABLE 01. GLOBAL INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 02. INTERVENTIONAL PULMONOLOGY MARKET FOR BRONCHOSCOPES, BY REGION, 2021-2031 ($MILLION)
TABLE 03. INTERVENTIONAL PULMONOLOGY MARKET FOR ELECTROMAGNETIC NAVIGATION BRONCHOSCOPY SYSTEM, BY REGION, 2021-2031 ($MILLION)
TABLE 04. INTERVENTIONAL PULMONOLOGY MARKET FOR PLEUROSCOPES, BY REGION, 2021-2031 ($MILLION)
TABLE 05. INTERVENTIONAL PULMONOLOGY MARKET FOR RESPIRATORY ENDOTHERAPY DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 06. INTERVENTIONAL PULMONOLOGY MARKET FOR AIRWAY STENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 07. INTERVENTIONAL PULMONOLOGY MARKET FOR PLEURAL CATHETERS, BY REGION, 2021-2031 ($MILLION)
TABLE 08. INTERVENTIONAL PULMONOLOGY MARKET FOR ENDOBRONCHIAL VALVES, BY REGION, 2021-2031 ($MILLION)
TABLE 09. INTERVENTIONAL PULMONOLOGY MARKET FOR BRONCHIAL THERMOPLASTY SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 10. GLOBAL INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 11. INTERVENTIONAL PULMONOLOGY MARKET FOR ASTHMA, BY REGION, 2021-2031 ($MILLION)
TABLE 12. INTERVENTIONAL PULMONOLOGY MARKET FOR COPD, BY REGION, 2021-2031 ($MILLION)
TABLE 13. INTERVENTIONAL PULMONOLOGY MARKET FOR LUNG CANCER, BY REGION, 2021-2031 ($MILLION)
TABLE 14. INTERVENTIONAL PULMONOLOGY MARKET FOR TRACHEAL AND BRONCHIAL STENOSIS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. INTERVENTIONAL PULMONOLOGY MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 16. GLOBAL INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 17. INTERVENTIONAL PULMONOLOGY MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 18. INTERVENTIONAL PULMONOLOGY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 19. INTERVENTIONAL PULMONOLOGY MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 20. INTERVENTIONAL PULMONOLOGY MARKET FOR SPECIALTY CLINICS, BY REGION, 2021-2031 ($MILLION)
TABLE 21. INTERVENTIONAL PULMONOLOGY MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 22. INTERVENTIONAL PULMONOLOGY MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 23. NORTH AMERICA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 24. NORTH AMERICA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 25. NORTH AMERICA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 26. NORTH AMERICA INTERVENTIONAL PULMONOLOGY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 27. U.S. INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 28. U.S. INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 29. U.S. INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 30. CANADA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 31. CANADA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 32. CANADA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 33. MEXICO INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 34. MEXICO INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 35. MEXICO INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 36. EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 37. EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 38. EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 39. EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 40. GERMANY INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 41. GERMANY INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 42. GERMANY INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 43. UK INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 44. UK INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 45. UK INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 46. FRANCE INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 47. FRANCE INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 48. FRANCE INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 49. SPAIN INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 50. SPAIN INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 51. SPAIN INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 52. ITALY INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 53. ITALY INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 54. ITALY INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 55. REST OF EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. REST OF EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 57. REST OF EUROPE INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 58. ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 59. ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 60. ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 61. ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 62. CHINA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 63. CHINA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 64. CHINA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 65. JAPAN INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 66. JAPAN INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 67. JAPAN INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 68. INDIA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 69. INDIA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 70. INDIA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 71. SOUTH KOREA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 72. SOUTH KOREA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 73. SOUTH KOREA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 74. AUSTRALIA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 75. AUSTRALIA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 76. AUSTRALIA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 77. REST OF ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 78. REST OF ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 79. REST OF ASIA-PACIFIC INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 80. LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 81. LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 82. LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 83. LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 84. BRAZIL INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 85. BRAZIL INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 86. BRAZIL INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 87. UNITED ARAB EMIRATES INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 88. UNITED ARAB EMIRATES INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 89. UNITED ARAB EMIRATES INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 90. SAUDI ARABIA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 91. SAUDI ARABIA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 92. SAUDI ARABIA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 93. SOUTH AFRICA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 94. SOUTH AFRICA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 95. SOUTH AFRICA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 96. REST OF LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 97. REST OF LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY INDICATION, 2021-2031 ($MILLION)
TABLE 98. REST OF LAMEA INTERVENTIONAL PULMONOLOGY MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 99. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 100. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 101. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 102. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 103. OLYMPUS CORPORATION: KEY EXECUTIVES
TABLE 104. OLYMPUS CORPORATION: COMPANY SNAPSHOT
TABLE 105. FUJIFILM CORPORATION: KEY EXECUTIVES
TABLE 106. FUJIFILM CORPORATION: COMPANY SNAPSHOT
TABLE 107. BECTON: KEY EXECUTIVES
TABLE 108. BECTON: COMPANY SNAPSHOT
TABLE 109. SMITH’S GROUP PLC: KEY EXECUTIVES
TABLE 110. SMITH’S GROUP PLC: COMPANY SNAPSHOT
TABLE 111. COOK MEDICAL: KEY EXECUTIVES
TABLE 112. COOK MEDICAL: COMPANY SNAPSHOT
TABLE 113. VYGON: KEY EXECUTIVES
TABLE 114. VYGON: COMPANY SNAPSHOT
TABLE 115. CLARUS MEDICAL LLC: KEY EXECUTIVES
TABLE 116. CLARUS MEDICAL LLC: COMPANY SNAPSHOT
TABLE 117. HUGER MEDICAL INSTRUMENT CO. LTD: KEY EXECUTIVES
TABLE 118. HUGER MEDICAL INSTRUMENT CO. LTD: COMPANY SNAPSHOT

★調査レポート[気管支インターベンションの世界市場2021-2031：機会分析・産業予測] (コード：ALD23JUN068)販売に関する免責事項を必ずご確認ください。
★調査レポート[気管支インターベンションの世界市場2021-2031：機会分析・産業予測]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 神経変性治療薬の世界市場2021-2031：機会分析・産業予測
  • 超個別化医療の世界市場2021-2031：機会分析・産業予測
  • 電気ヒューズの世界市場2021-2031：機会分析・産業予測
  • アテローム切除術機器の世界市場2021-2031：機会分析・産業予測
  • 尿分析検査の世界市場2021-2031：機会分析・産業予測
  • 肥満介入装置の世界市場2021-2031：機会分析・産業予測
  • セントラルラボの世界市場2022-2031：機会分析・産業予測
  • 脳マッピング機器の世界市場2021-2031：機会分析・産業予測
  • 温熱療法の世界市場2021-2031：機会分析・産業予測
  • 精密発酵の世界市場2021-2031：機会分析・産業予測

    • ◆H&Iグローバルリサーチのお客様（例）◆